ANTI-DIURETIC HORMONE (ADH) / VASOPRESSIN

ANTI-DIURETIC HORMONE (ADH) / VASOPRESSIN


ANTI-DIURETIC HORMONE (ADH) / VASOPRESSIN

SYNTHESIS: 

  • In Hypothalamus 
  • Supra-optic nucleus 
  • Along with binding protein Neurophysin-I

STORAGE AND SECRETION:

  • Stored in Pituicytes
  • Secreted by Posterior pituitary
  • Circulating free forms 

RECEPTORS:

RECEPTOR TYPE  SITE OF ACTION & FUNCTION 
V1

V1 a





V1 b / V3

Blood vessels – 

Visceral smooth muscle 

Vaso-constriction &

Smooth muscle

contraction

Anterior Pituitary 

V2

V2 receptors are

more sensitive to ADH

than V1

 

Kidney

Blood vessel – 

Increased water permeability 

Vaso-dilatation 

Release of vWf & Factor VIII

Regulation of secretion:

  • By Osmoregulators
  • Circum-ventricular organs, primarily from 

– Organum Vasculosum of Lateral Terminalis (OVLT)

– Antero-lateral wall in 3rd ventricle

– Sub-Fronical Organ (SFO) 

Factors:

Stimulating factors (Main physiological stimuli):

  • Hyperosmolarity
  • Decreased ECF volume
  • Low blood volume
  • Drugs – Carbamazepine, Morphine
  • Angiotensin-II.
  • Pain, exercise & stress
  • Sleep

Inhibiting factors:

  • Hypo-osmolarity (Decreased osmolarity)
  • Increased ECF
  • Alcohol 
  • Cold environment

Principle physiological actions:

Effects on Kidney:

  • Retention of water:

– Increase permeability & water absorption 

– In collecting ducts & distal convoluted tubule

Effects on Blood vessel:

  • Constrict blood vessel – Hence, “VASOPRESSIN”

Required output:

  • Decreasing effective osmotic pressure
  • Increasing osmolality of body fluid

CONDITIONS ASSOCIATED:

Disorders with increased ADH:

  • Syndrome of inappropriate ADH secretion
  • Effective circulating volume depletion
  • Heart failure 
  • Cirrhosis
  • Thiazide diuretics

Disorders with decreased ADH:

  • Advanced renal failure
  • Primary polydipsia

APPLIED PHYSIOLOGY:

Hyper-secretion of ADH:

SYNDROME OF INAPPROPRIATE ADH SECRETION (SIADH):

  • Increased & inappropriate vasopressin release
  • Secretion occurs despite decreased plasma osmolality 
  • Hence termed “Inappropriate”

Physiological characteristics:

  • Excessive fluid retention (Water intoxication)
  • Hyperosmolar urine 
  • Clinical Euvolemia

– Absence of signs of hypervolemia (edema)

  • Hyponatremia

– due to impaired urinary dilution

  • Increased sodium excretion 

– High urinary sodium

  • Absence of signs of hypovolemia

– orthostatic hypotension, tachycardia & dehydration 

  • Absence of cardiac, liver or renal disease
  • Normal thyroid and adrenal function

Causes:

  • Ectopic production from carcinomas

– Mainly Small cell carcinoma of Lung

  • Drugs potentiating ADH effects 

– Vincristine 

Investigations: 

  • Water loading test 

Treatment:

  • Restriction of fluid intake
  • Administration of hypertonic saline  

Nonspecific ADH antagonists:

  • Demeclocycline & Lithium
  • Antagonize ADH in collecting tubules
  • Inhibiting formation of CAMP.

Specific ADH antagonist:

  • Selective V2 receptor antagonist.
  • Tolvaptan.

Hyposecretion of ADH:

DIABETES INSIPIDUS:

Types:

  • Central
  • Nephrogenic 

Central diabetes insipidus:

  • Failure to produce ADH

Causes:

  • Head injuries 
  • Infections
  • Congenital causes

Characteristics features:

  • Large volumes of dilute urine formation 
  • Resulting in severe dehydration in unconscious patients 

Treatment:

  • Synthetic analog of ADH 

– Desmopressin

– Acts on V2 receptors

– Increase water permeability in distal & collecting tubules

Nephrogenic diabetes insipidus:
  • Inability of kidney to respond to ADH
  • Renal tubule resistance/ Hyposensitivity 
  • Irresponsive to ADH action
Causes:
  • Failure of, 
  • Forming hyper-osmotic counter-current mechanism
  • ADH response to renal distal & collecting ducts & tubules 
  • Impairment of loop of Henle
  • Drugs –Furosemide, Lithium & Tetracyclin

Features:

  • Clinical features same as central type

Difference bt. Central & Nephrogenic types:

  • Administrating synthetic analog of ADH

– Lack of prompt decrease in urine volume 

  • Increase in urine osmolarity < 2 hours 

– Strongly suggestive of nephrogenic type.

  • ?     selective V2 receptor antagonist.

Exam Important

ANTI-DIURETIC HORMONE (ADH) / VASOPRESSIN

SYNTHESIS: 

  • In Hypothalamus 
  • Supra-optic nucleus 
  • Along with binding protein Neurophysin-I
  • Stored in Pituicytes
RECEPTORS:
RECEPTOR TYPE  SITE OF ACTION 
V1

 

Blood vessels 

Vaso-constriction

V2

V2 receptors are more

sensitive

to ADH than V1

 

Kidney

Blood vessel – 

Increased water permeability 

Vaso-dilatation 

Release of vWf & Factor VIII

Regulation of secretion:

  • By Osmoregulators
  • Circum-ventricular organs, primarily from 

– Organum Vasculosum of Lateral Terminalis (OVLT)

– Antero-lateral wall in 3rd ventricle

Stimulating factors:

  • Hyperosmolarity
  • Decreased ECF volume
  • Drugs – Carbamazepine, Morphine
Inhibiting factors: 

  • Hypo-osmolarity (Decreased osmolarity)
  • Increased ECF
  • Alcohol
Principle physiological effects:

Effects on Kidney:

  • Retention of water:

– Increase permeability & water absorption 

Effects on Blood vessel:

  • Constrict blood vessel – Hence, “VASOPRESSIN”
Disorders with increased ADH:

  • Syndrome of inappropriate ADH secretion
  • Effective circulating volume depletion
  • Heart failure 

SYNDROME OF INAPPROPRIATE ADH SECRETION (SIADH):

  • Increased & inappropriate vasopressin release,

Characteristics:

  • Excessive fluid retention (Water intoxication)
  • Hyperosmolar urine
  • Clinical Euvolemia

– Absence of signs of hypervolemia (edema)

  • Hyponatremia

– due to impaired urinary dilution

  • Increased sodium excretion

– High urinary sodium

  • Absence of signs of hypovolemia

– orthostatic hypotension, tachycardia & dehydration 

Causes:

  • Ectopic production from carcinomas

– Mainly Small cell carcinoma of Lung

  • Drugs potentiating ADH effects

– Vincristine

Investigations: 

  • Water loading test 

Treatment:

  • Demeclocycline & Lithium

Central Diabetes insipidus:

  • Characteristics features:

– Large volumes of dilute urine formation 

– Resulting in severe dehydration in unconscious patients 

Treatment:

  • Desmopressin
Nephrogenic diabetes insipidus:
  • Renal tubule resistance/ Hyposensitivity 
  • Irresponsive to ADH action
  • Causes:
  • Failure of forming hyper-osmotic counter-current mechanism 
  • Drugs – Furosemide, Lithium & Tetracyclin
Difference central & nephrogenic types:
  • By administrating synthetic analog of ADH
Don’t Forget to Solve all the previous Year Question asked on ANTI-DIURETIC HORMONE (ADH) / VASOPRESSIN
Click Here to Start Quiz

Module Below Start Quiz

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support